Hantavirus infection: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} Sin nombre virus infection | {{SK}} Sin nombre virus infection; Hantavirus cardiopulmonary syndrome (HCPS) | ||
== [[Hantavirus pulmonary syndrome overview|Overview]] == | == [[Hantavirus pulmonary syndrome overview|Overview]] == | ||
Revision as of 18:35, 10 August 2015
This page is about clinical aspects of the disease. For microbiologic aspects of the causative organism(s), see Hantavirus.
For patient information, click here Template:Hantavirus pulmonary syndrome Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Sin nombre virus infection; Hantavirus cardiopulmonary syndrome (HCPS)
Overview
Historical Perspective
Pathophysiology
Differentiating Hantavirus pulmonary syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D. List of contributors: Pilar Almonacid